Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation.
暂无分享,去创建一个
H. Nagasawa | Y. Uto | H. Hori | S. Mohamad
[1] D. Cook,et al. Lectin immunoassay for macrophage-activating factor (Gc-MAF) produced by deglycosylation of Gc-globulin: evidence for noninducible generation of Gc-MAF. , 2000, Clinical chemistry.
[2] K. Ohkura,et al. Elucidation of strict structural requirements of brefeldin A as an inducer of differentiation and apoptosis. , 2000, Bioorganic & medicinal chemistry.
[3] H. Nagasawa,et al. Apoptosis induction in HCT116 cells by cytochalasins isolated from the fungus Daldinia vernicosa. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[4] D. Wakefield,et al. Abundant expression of chemokines in malignant and infective human lymphadenopathies. , 1999, Cytokine.
[5] M. Páez de la Cadena,et al. N-Acetyl-β-Hexosaminidase Activity and Isoenzymes in Human Gastric Adenocarcinoma , 1999, Oncology.
[6] N. Yamamoto,et al. Antitumor Effect of Vitamin D-Binding Protein-Derived Macrophage Activating Factor on Ehrlich Ascites Tumor-Bearing Mice , 1999 .
[7] R. Beavis,et al. Structural studies of alpha-N-acetylgalactosaminidase: effect of glycosylation on the level of expression, secretion efficiency, and enzyme activity. , 1998, Archives of biochemistry and biophysics.
[8] N. Yamamoto,et al. Deglycosylation of serum vitamin D3-binding protein by alpha-N-acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus. , 1997, Clinical immunology and immunopathology.
[9] M. Páez de la Cadena,et al. Alterations of glycosidases in human colonic adenocarcinoma. , 1997, Clinical biochemistry.
[10] N. Yamamoto,et al. Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients. , 1997, Cancer research.
[11] N. Yamamoto. Structural definition of a potent macrophage activating factor derived from vitamin D3-binding protein with adjuvant activity for antibody production. , 1996, Molecular immunology.
[12] R. Ray. Molecular Recognition in Vitamin D-Binding Protein , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[13] S. Asbell,et al. Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients. , 1996, Cancer research.
[14] T. Kudo,et al. Synthesis and activity of 1-N-iminosugar inhibitors, siastatin B analogues for alpha-N-acetylgalactosaminidase and beta-N-acetylglucosaminidase. , 1996, Bioorganic & medicinal chemistry.
[15] I. Yamamoto,et al. Enzymatically modified Gc globulin induces the translocation of Fc.GAMMA.R I and Fc.GAMMA.RII from intracellular storage compartments to the cell surface in murine peritoneal macrophages. , 1995 .
[16] R. Frairia,et al. The hepatic receptor for sex steroid-binding protein: study on a non-malignant cell line (Chang liver). , 1993, Journal of molecular endocrinology.
[17] S. Josephs,et al. Regulation of HIV-1 LTR trans-activating activities in two different human hepatocellular carcinoma cell lines. , 1993, Cancer letters.
[18] R. Desnick,et al. Overexpression of human alpha-galactosidase A results in its intracellular aggregation, crystallization in lysosomes, and selective secretion , 1992, The Journal of cell biology.
[19] R. Desnick,et al. Structural organization and complete sequence of the human alpha-N-acetylgalactosaminidase gene: homology with the alpha-galactosidase A gene provides evidence for evolution from a common ancestral gene. , 1991, Genomics.
[20] Anne M. Wang,et al. Schindler disease: the molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes an infantile neuroaxonal dystrophy. , 1990, The Journal of clinical investigation.
[21] I. Goldstein,et al. Glycosidases of ehrlich ascites tumor cells and ascitic fluid—Purification and substrate specificity of α-N-Acetylgalactosaminidase and α-galactosidase: Comparison with coffee bean α-galactosidase , 1990 .
[22] I. Goldstein,et al. Glycosidases of Ehrlich ascites tumor cells and ascitic fluid--purification and substrate specificity of alpha-N-acetylgalactosaminidase and alpha-galactosidase: comparison with coffee bean alpha-galactosidase. , 1990, Archives of biochemistry and biophysics.
[23] S. Tsuji. Molecular cloning of a full-length cDNA for human ?-N-acetylgalactosaminidase (?-galactosidase B) , 1989 .
[24] Anne M. Wang,et al. Neuroaxonal Dystrophy Due to Lysosomal α-N-Acetylgalactosaminidase Deficiency , 1989 .
[25] R. Desnick,et al. Neuroaxonal dystrophy due to lysosomal alpha-N-acetylgalactosaminidase deficiency. , 1989, The New England journal of medicine.
[26] K. Sakimura,et al. Molecular cloning of a full-length cDNA for human alpha-N-acetylgalactosaminidase (alpha-galactosidase B). , 1989, Biochemical and Biophysical Research Communications - BBRC.
[27] J. Montreuil,et al. Isolation and characterization of the O-glycan chain of the human vitamin-D binding protein. , 1983, Biochemical and biophysical research communications.
[28] R. Schultz,et al. Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel. , 1978, Cancer treatment reports.
[29] Z. Cohn,et al. Increased superoxide anion production by immunologically activated and chemically elicited macrophages , 1978, The Journal of experimental medicine.
[30] E. Davidson,et al. Purification and properties of an endo-alpha-N-acetyl-D-galactosaminidase from Diplococcus pneumoniae. , 1977, The Journal of biological chemistry.
[31] Chang Rs. Continuous subcultivation of epithelial-like cells from normal human tissues. , 1954 .
[32] J. Snyder,et al. Continuous Subcultivation of Epithelial-like Cells from Normal Human Tissues.∗ , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.